Look to MaxCyte’s fully scalable, cGMP-compliant delivery platform to develop innovative vaccines and optimized manufacturing that offer shorter lead times and greater production flexibility while maintaining vaccine safety. No other delivery platform offers the ability to develop and manufacture the full complement of next-generation vaccines
Recombinant Protein & Antigen Production
Dendritic Cell Vaccines
Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter